- Home
- HUIZ vs CING Comparison
HUIZ vs CING Comparison
Compare HUIZ & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- CING
- Stock Information
- Founded
- HUIZ 2006
- CING 2012
- Country
- HUIZ China
- CING United States
- Employees
- HUIZ N/A
- CING N/A
- Industry
- HUIZ Specialty Insurers
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- CING Health Care
- Exchange
- HUIZ Nasdaq
- CING Nasdaq
- Market Cap
- HUIZ 18.8M
- CING 16.2M
- IPO Year
- HUIZ 2020
- CING 2021
- Fundamental
- Price
- HUIZ $2.26
- CING $4.25
- Analyst Decision
- HUIZ
- CING Strong Buy
- Analyst Count
- HUIZ 0
- CING 4
- Target Price
- HUIZ N/A
- CING $30.67
- AVG Volume (30 Days)
- HUIZ 65.5K
- CING 125.0K
- Earning Date
- HUIZ 05-27-2025
- CING 05-08-2025
- Dividend Yield
- HUIZ N/A
- CING N/A
- EPS Growth
- HUIZ N/A
- CING N/A
- EPS
- HUIZ N/A
- CING N/A
- Revenue
- HUIZ $171,105,205.00
- CING N/A
- Revenue This Year
- HUIZ $6.81
- CING N/A
- Revenue Next Year
- HUIZ $9.30
- CING N/A
- P/E Ratio
- HUIZ N/A
- CING N/A
- Revenue Growth
- HUIZ 4.46
- CING N/A
- 52 Week Low
- HUIZ $1.50
- CING $1.80
- 52 Week High
- HUIZ $10.58
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- HUIZ 54.25
- CING 55.08
- Support Level
- HUIZ $2.10
- CING $3.83
- Resistance Level
- HUIZ $2.43
- CING $4.15
- Average True Range (ATR)
- HUIZ 0.29
- CING 0.30
- MACD
- HUIZ 0.06
- CING -0.02
- Stochastic Oscillator
- HUIZ 73.44
- CING 64.94
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.